Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer

Therapeutic Advances in Medical Oncology ◽

10.1177/1758834010365061 ◽

2010 ◽

Vol 2 (3) ◽

pp. 161-174 ◽

Author(s):

Stefan Peinert ◽

Wilfried Grothe ◽

Alexander Stein ◽

Lutz P. Müller ◽

Joern Ruessel ◽

...

Keyword(s):

Folinic Acid ◽

Gastrointestinal Cancer ◽

Line Treatment ◽

Safety And Efficacy ◽

First Line Treatment

Download Full-text

Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): Results of the safety and efficacy analysis

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3507 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3507-3507 ◽

Author(s):

H.-T. Arkenau ◽

H. Schmoll ◽

S. Kubicka ◽

A. Kretzschmar ◽

W. Freier ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Line Treatment ◽

Safety And Efficacy ◽

Efficacy Analysis ◽

First Line Treatment

Download Full-text

Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus Capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): Results of an interim safety and efficacy analysis

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-920176 ◽

2005 ◽

Vol 43 (05) ◽

Author(s):

R Porschen ◽

HT Arkenau ◽

S Kubicka ◽

T Seufferlein ◽

U Graeven ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Line Treatment ◽

Metastatic Colorectal Carcinoma ◽

Safety And Efficacy ◽

Efficacy Analysis ◽

First Line Treatment

Download Full-text

601 ORAL Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80897-3 ◽

2005 ◽

Vol 3 (2) ◽

pp. 168 ◽

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Line Treatment ◽

Metastatic Colorectal Carcinoma ◽

Safety And Efficacy ◽

Efficacy Analysis ◽

First Line Treatment

Download Full-text

6504 ORAL Safety and Efficacy of Epirubicin, Cisplatin, and Capecitabine (ECX) Plus Rilotumumab (R) as First-line Treatment for Unresectable Locally Advanced (LA) or Metastatic (M) Gastric or Esophagogastric Junction (EGJ) Adenocarcinoma

European Journal of Cancer ◽

10.1016/s0959-8049(11)71815-9 ◽

2011 ◽

Vol 47 ◽

pp. S443 ◽

Author(s):

T. Iveson ◽

R.C. Donehower ◽

I. Davidenko ◽

S. Tjulandin ◽

A. Deptala ◽

...

Keyword(s):

Esophagogastric Junction ◽

Locally Advanced ◽

Line Treatment ◽

Safety And Efficacy ◽

First Line Treatment

Download Full-text

A Retrospective Study of the Safety and Efficacy of a First-Line Treatment with Modified FOLFOX-4 in Unresectable Advanced or Recurrent Gastric Cancer Patients

Chemotherapy ◽

10.1159/000345742 ◽

2012 ◽

Vol 58 (5) ◽

pp. 411-418 ◽

Author(s):

Yung-Sung Yeh ◽

Hsiang-Lin Tsai ◽

Cheng-Jen Ma ◽

Deng-Chyang Wu ◽

Chien-Yu Lu ◽

...

Keyword(s):

Gastric Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Line Treatment ◽

Safety And Efficacy ◽

Recurrent Gastric Cancer ◽

Gastric Cancer Patients ◽

First Line Treatment

Download Full-text

Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study

European Journal of Cancer ◽

10.1016/j.ejca.2020.02.002 ◽

2020 ◽

Vol 129 ◽

pp. 97-106 ◽

Author(s):

Akihito Kawazoe ◽

Kensei Yamaguchi ◽

Hisateru Yasui ◽

Yuji Negoro ◽

Mizutomo Azuma ◽

...

Keyword(s):

Gastroesophageal Junction ◽

Line Treatment ◽

Safety And Efficacy ◽

Gastroesophageal Junction Cancer ◽

First Line Treatment

Download Full-text

Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies

Annals of Oncology ◽

10.1093/annonc/mdw335.14 ◽

2016 ◽

Vol 27 ◽

pp. iv43

Author(s):

D. Rossini ◽

M. Casagrande ◽

R. Moretto ◽

F. Loupakis ◽

C. Cremolini ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Pooled Analysis ◽

Line Treatment ◽

Targeted Agents ◽

Safety And Efficacy ◽

Colorectal Cancer Patients ◽

First Line Treatment

Download Full-text

Safety and Efficacy of Albumin-Bound Paclitaxel and Oxaliplatin and S-1 as First-Line Treatment of Patients with advanced Gastric Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33250-6 ◽

2012 ◽

Vol 23 ◽

pp. ix256

Author(s):

H. Lou ◽

H. Pan ◽

Q. Pan ◽

D. Li ◽

W. Jin

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Line Treatment ◽

Safety And Efficacy ◽

First Line Treatment

Download Full-text

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

Annals of Oncology ◽

10.1093/annonc/mdm544 ◽

2008 ◽

Vol 19 (5) ◽

pp. 920-926 ◽

Author(s):

C.-H. Köhne ◽

J. De Greve ◽

J.T. Hartmann ◽

I. Lang ◽

P. Vergauwe ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment in advanced colorectal carcinoma (ACRC): Results of an interim safety analysis

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3546 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3546-3546

Author(s):

H.-T. Arkenau ◽

H. Schmoll ◽

S. Kubicka ◽

T. Seufferlein ◽

P. Reichardt ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Safety Analysis ◽

Phase Iii ◽

Line Treatment ◽

Phase Iii Trial ◽

Advanced Colorectal Carcinoma ◽

First Line Treatment

Download Full-text